The Multi-Specialty Site Organization Built for Speed, Quality, & Reliable Enrollment
Tekton helps Sponsors, CROs, and biotech teams accelerate research programs by delivering reliable site performance. Experienced investigators, engaged patient communities, and agile operations make studies easier to start, enroll, run, and complete.
Neurology & Psychiatry
Engage experienced investigators and ready patient populations across complex neurologic and psychiatric research.
Depression • Pain • Alzheimer's Disease • Migraine • Addiction • Other neurologic and psychiatric conditions
Cardiometabolic & Endocrinology
Partner with sites experienced in cardiometabolic, endocrine, and multi-comorbidity research.
Type 1 Diabetes • Type 2 Diabetes • Obesity • MASH/MASLD • Thyroid • Endocrinology • Related and overlapping metabolic conditions
General Medicine
Reach large, well-profiled patient populations across common chronic and general medicine indications.
Allergy • COPD • Asthma • Atopic Dermatitis • Other general medicine conditions
The Latest From Tekton
-
FDA Approves ILUMYA for Adults With Active Psoriatic Arthritis
Paul Pickrell, MD, and Tekton’s Austin team supported INSPIRE 1, one of the Phase 3 studies behind ILUMYA’s new approval for active psoriatic arthritis.
-
Patient Recruitment Q&A With Stefanie Hunter
Stefanie Hunter, VP, Patient Strategy, shares what she’s learned about recruitment, earning trust, showing up in the community, and listening to participants.
-
Introducing the Tekton Alzheimer’s Team
Tekton is introducing its Alzheimer’s Team, bringing together practicing physician-investigators, experienced neuroscience raters, and clinical and operational leaders to advance research across six lead sites. The team’s focus includes Alzheimer’s … Read more
-
Watch Jara McDonald, MD, on the Physician-Led Advantage
In the Society for Clinical Research Sites (SCRS) webinar, “The Physician-Led Advantage: Strengthening Site-Sponsor-CRO Partnerships,” Jara McDonald, MD, FAAFP, DABOM, CPI, Tekton’s Executive Medical Director and Cardiometabolic Research Lead, shared … Read more